INVA Innoviva Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INVA

Price (delayed)

$14.44

Market cap

$925.41M

P/E Ratio

17.83

Dividend/share

N/A

EPS

$0.81

Enterprise value

$1.19B

Innoviva, Inc. is a healthcare focused asset management company. The Company intends to participate in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva operates in the United States.

Highlights
The debt has contracted by 17% YoY
Innoviva's quick ratio has increased by 6% from the previous quarter
The equity has increased by 13% since the previous quarter but it has declined by 2.2% year-on-year
The stock's price to earnings (P/E) is 158% more than its last 4 quarters average of 6.9
INVA's net income has dropped by 83% year-on-year and by 79% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.inva.com
Peers: OGN

Key stats

What are the main financial stats of INVA
Market
Shares outstanding
64.09M
Market cap
$925.41M
Enterprise value
$1.19B
Valuations
Price to earnings (P/E)
17.83
Price to book (P/B)
1.5
Price to sales (P/S)
3.23
EV/EBIT
13.94
EV/EBITDA
10.08
EV/Sales
4.1
Earnings
Revenue
$290.43M
EBIT
$85.44M
EBITDA
$118.16M
Free cash flow
$116.41M
Per share
EPS
$0.81
Free cash flow per share
$1.79
Book value per share
$9.64
Revenue per share
$4.47
TBVPS
$14.37
Balance sheet
Total assets
$1.19B
Total liabilities
$560.61M
Debt
$445.72M
Equity
$627.49M
Working capital
$268.82M
Liquidity
Debt to equity
0.71
Current ratio
8.43
Quick ratio
6.85
Net debt/EBITDA
2.25
Margins
EBITDA margin
40.7%
Gross margin
86.4%
Net margin
17.2%
Operating margin
32.2%
Efficiency
Return on assets
4.3%
Return on equity
8.6%
Return on invested capital
7.7%
Return on capital employed
7.4%
Return on sales
29.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INVA stock price

How has the Innoviva stock price performed over time
Intraday
-1.7%
1 week
5.48%
1 month
5.79%
1 year
10.14%
YTD
8.98%
QTD
11.16%

Financial performance

How have Innoviva's revenue and profit performed over time
Revenue
$290.43M
Gross profit
$250.8M
Operating income
$93.63M
Net income
$49.88M
Gross margin
86.4%
Net margin
17.2%
INVA's net income has dropped by 83% year-on-year and by 79% since the previous quarter
INVA's operating income has shrunk by 83% YoY and by 74% QoQ
The net margin has plunged by 79% from the previous quarter and by 78% YoY
The operating margin has plunged by 78% YoY and by 74% from the previous quarter

Growth

What is Innoviva's growth rate over time

Valuation

What is Innoviva stock price valuation
INVA P/E details
P/E
17.83
P/B
1.5
P/S
3.23
EV/EBIT
13.94
EV/EBITDA
10.08
EV/Sales
4.1
The stock's price to earnings (P/E) is 158% more than its last 4 quarters average of 6.9
The company's EPS has shrunk by 81% YoY and by 76% QoQ
The P/B is 57% below the 5-year quarterly average of 3.5
The equity has increased by 13% since the previous quarter but it has declined by 2.2% year-on-year
The revenue has contracted by 22% YoY
The P/S is 20% higher than the last 4 quarters average of 2.7 but 15% lower than the 5-year quarterly average of 3.8

Efficiency

How efficient is Innoviva business performance
INVA's return on equity has dropped by 87% year-on-year and by 79% since the previous quarter
INVA's ROA has plunged by 83% YoY and by 78% from the previous quarter
The return on invested capital has dropped by 77% year-on-year and by 74% since the previous quarter
The company's return on sales has shrunk by 74% QoQ and by 71% YoY

Dividends

What is INVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INVA.

Financial health

How did Innoviva financials performed over time
The total assets is 112% greater than the total liabilities
The total liabilities has decreased by 18% YoY
The total assets has declined by 11% year-on-year but it rose by 6% since the previous quarter
The debt is 29% less than the equity
The debt has contracted by 17% YoY
The debt to equity has declined by 15% year-on-year and by 11% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.